Status:
TERMINATED
Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
At least 20% of patients hospitalized in the general medical and surgical wards at any given time suffer from diabetes. It has been demonstrated that poor clinical outcome correlates with the degree o...
Detailed Description
Location of the study: Internal Medicine Wards C of Assaf Harofe Medical Center, Zerifin, Israel: Inclusion Criteria: * Adult (\<18 years) Male and female T1 \& T2DM patients who can sign an inform...
Eligibility Criteria
Inclusion
- Adult (\<18 years) Male and female T1 \& T2DM patients who can sign an informed consent.
- Insulin treatment (at least one injection a day) prior to hospitalization for at least half a year.
Exclusion
- Diabetic ketoacidosis.
- Hyperosmolar state due to hyperglycemia.
- Pregnancy
- Fertile women who do not use oral contraception or IUD
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00464854
Start Date
July 1 2005
End Date
September 1 2006
Last Update
April 24 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf Harofe Medical Center
Ẕerifin, Israel, 70300